- [PRESSWIRE] SEATTLE, June 19, 2019 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, has selected BardyDx to participate in the organization’s 2019 Showcase program, featuring the most promising medical technologies from around the globe.
- [PRESSWIRE] Budapest – June 14, 2019 — Kidney transplantation is the treatment of choice for most people with kidney failure, as it will improve their survival while increasing their quality of life compared to remaining on dialysis.
- [PRESSWIRE] Budapest – June 14, 2019 — In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. This was associated with a high incidence of cardiovascular/kidney disease but this secondary disease burden could not be lowered by linagliptin.
- [PRESSWIRE] Budapest – June 14, 2019 — 26% of patients had been employed 6 months prior to dialysis initiation – but this dropped to 15% when dialysis treatment was initiated.
- [PRESSWIRE] Budapest, June 14, 2019 – As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body, a condition known as metabolic acidosis.
- [PRESSWIRE] Budapest – June 14, 2019 — Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful – and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research.
- [PRESSWIRE] Budapest – June 14, 2019 — Acute kidney injury (AKI) is a common complication after cardiac surgery. The severity fluctuates from subclinical AKI, an increase in biochemical markers of kidney injury, to severe AKI requiring renal replacement therapy with dialysis.
- [PRESSWIRE] Budapest – June 13, 2019 — Alport syndrome (AS) is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.
- [PRESSWIRE] Budapest – June 13, 2019 — High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.
- [PRESSWIRE] Budapest – June 13, 2019 — Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials.
- [PRESSWIRE]10 June, 2019 – Vancouver, British Columbia — Harvest One (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through it’s wholly-owned subsidiary Satipharm Ltd. (“Satipharm”) today announced that it has entered into an agreement to distribute their proprietary Satipharm CBD 10mg Gelpell® through Holland & Barrett, Europe’s largest retailer of nutritional supplements and wellness products with over 145 years of experience in the health and wellness industry.
- [PRESSWIRE] NETANYA, Israel, June 4, 2019 — Eitan Group, a global leader in advanced infusion therapy solutions across the care continuum, today announced the opening of a new office in Southern California. The new US Headquarters will be based in Aliso Viejo and will be led by Eitan Group North America CEO, Roger Massengale, to support purchasing, training and service-related needs.
- [PRESSWIRE] Hungary – 09 May, 2019 — People go from all parts of the world to Budapest (Hungary, Europe) to get their teeth fixed and save up to 70% on dental care. It is no matter if it is about a complete smile makeover or just some lost teeth should be replaced by implants or a couple of crowns should be fitted, one of the most preferred destinations is Budapest.
- [PRESSWIRE] LAGUNA HILLS, Calif. – May 1, 2019 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, will present interim results from its large PREDICT study during a poster presentation (Abstract ID: 581643), titled “Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy (RT) Benefit in Patients with DCIS”, at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Dallas, TX.
- [PRESSWIRE] Parma – April 26, 2019 — The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).
- [PRESSWIRE] Parma – 18 April 2019 — Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people. One recently published study [1] shows current data and derives important conclusions for further long-term improvements in outcomes after kidney transplantation – a highly topical issue, especially for cost reasons and in the event of organ or donor scarcity.
- [PRESSWIRE] Parma – 10 April, 2019 — Chronic kidney disease (CKD) is increasingly recognized as a systemic condition. It also impacts upon other organ systems and in recent years much attention has focussed specifically on the link between the kidneys and the heart. There is also an association between brain dysfunction and kidney disease; new data shows that even mild CKD correlates with impairment of cognitive function. A new review by Professor Giovambattista Capasso summarizes the current evidence in this field.
- [PRESSWIRE] CHICAGO, April 9, 2019 — Citizens United for Research in Epilepsy (CURE) announced today the appointment of Beth Lewin Dean, MBA, MPA as the new Chief Executive Officer. Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.
- [PRESSWIRE] YORBA LINDA, Calif., April 9, 2019 — Breaking from the traditional format of Liveyon’s live ‘Pure-Cast,’ Liveyon founder and CEO sat down with his mother, Lois Christianson, in a heartfelt conversation on how stem cell treatment saved her life after a horrifying injury.
- [PRESSWIRE] MOUNTAIN VIEW, Calif., April 1, 2019 — GetInsured, a leading provider of health insurance marketplace platforms, has abolished $1,856,771.28 of residents’ medical debt in its home state of California, to help alleviate some of the severe financial hardship caused by unpaid and un-payable medical bills.
- [PRESSWIRE] PEORIA, Ill., March 27, 2019 — A new collaboration between Peoria, Illinois-based OSF HealthCare and Redox, based in Madison, Wisconsin, will allow the health system to effectively integrate pilot programs and deploy digital health solutions to improve health for OSF HealthCare communities. Redox will serve as an application layer connecting third-party technology solutions to the OSF HealthCare clinical systems.
- [PRESSWIRE] SAN DIEGO, March 27, 2019 — Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced three presentations of updated clinical and preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2019, to be held March 29-April 3 in Atlanta and the 2019 American Association of Neurological Surgeons (AANS) Annual Meeting, to be held April 13-17 in San Diego.
- [PRESSWIRE] NEW YORK and BASEL, Switzerland, March 19, 2019 — Today Roivant subsidiary Urovant Sciences announced topline results from its Phase 3 EMPOWUR trial of vibegron in patients with overactive bladder. Vibegron achieved statistically significant improvements over placebo on both co-primary endpoints of the study as well as all seven key secondary endpoints. Over 30 million Americans over the age of 40 suffer from overactive bladder.
- [PRESSWIRE] Parma – 05 March, 2019 — “Kidney health for everyone everywhere” – ERA-EDTA has helped to put this motto into practice by offering support for young nephrologists living in disadvantage areas.
- [PRESSWIRE] Parma – 05 March, 2019 — 850 million people worldwide are affected by kidney disease [1] – a worrying figure, and one that continues to rise. Prevention of chronic kidney disease is therefore more important than ever, as Professor Carmine Zoccali (Reggio Calabria, Italy), President of the ERA-EDTA, emphasizes on the occasion of World Kidney Day on March 14, 2019.
- [PRESSWIRE] Brussels, 28 February 2019 – Today, Digestive Cancers Europe launched a campaign to promote colorectal cancer screening at the occasion of the start of European Colon Cancer Awareness Month (ECCAM). The event took place at the European Parliament and was hosted by MEP Lieve Wierinck (ALDE).
- [PRESSWIRE] Parma – 26 February, 2019 — A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.
- [PRESSWIRE] – Parma – February 18, 2019 — Results bear one clear key message: good treatment is important! Patients in whom the acidosis had been properly controlled by adequate treatment had better growth and better kidney function than those with inadequate treatment.
- [PRESSWIRE] Parma – January 31, 2019 — 850 million people worldwide are affected by kidney disease. This worrying figure was published last June by the three leading nephrology societies (ASN, ISN and ERA-EDTA) [1] – and it continues to rise at an alarming rate.
- [PRESSWIRE] Germany – 21 December, 2018 — A study published in JAMA [1] showed: Nephrologists treat the most complex patients. As ERA-EDTA president Professor Carmine Zoccali explains, kidney patients are highly vulnerable and need special care, but nephrology is a neglected discipline in many European healthcare systems. According to the “European Renal Association – European Dialysis and Transplant Association” (ERA-EDTA) it is time for a paradigm shift. There is a need for a better financial funding of nephrology – as well as more efforts to raise awareness for kidney disease in the population.